Melanie Saville

Executive Director of Vaccine Research & Development

CEPI

Melanie Saville (MB BS) joined the Coalition for Epidemic Preparedness Innovations (CEPI) in November 2017. She is the Executive Director of Vaccine Research & Development, and leads the technical teams supporting the vaccine development and enabling science projects funded by CEPI and is the R&D and Manufacturing workstream leader for COVAX.

Melanie is a physician specialized in virology with 20 yrs of experience in the development and licensure of vaccines for the developed and developing world. Over the years, she has contributed to the development and licensure of several vaccines for seasonal and pandemic influenza, pediatric combinations, Rabies, Japanese Encephalitis and Dengue vaccine in Europe, US and the international area. She is currently a Board member of the International Vaccine Institute (IVI).

Melanie obtained her medical degree from University College, London in 1993. She also obtained a Bachelor of Science in Molecular Biology from University College, London and a master's in medical Virology from Imperial College, London. In the vaccine industry, Melanie has held positions of increasing responsibility in research and development working for Wyeth, Sanofi Pasteur and Janssen vaccines and prevention.